DMCC Speciality Chemicals Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 28 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹710 Cr

The company does not provide specific futuristic sales, revenue, or volume projections, maintaining a conservative approach to forward guidance. The management, represented by Bimal Goculdas, refrains from giving futuristic projections, maintaining focus on past and present performance.

From DMCC Speciality Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

284

Market Cap

₹710 Cr

P/E Ratio

26.0

Revenue Rank

Rank 4

Margin Rank

Rank 3

How does DMCC Speciality Chemicals Ltd rank in Chemicals & Petrochemicals?

Compare DMCC Speciality Chemicals Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 4Margin: Rank 3
View Chemicals & Petrochemicals leaderboard →

DMCC Speciality Chemicals Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹178 Cr, net profit ₹8 Cr.

Full financials →

📊 Revenue & Sales Performance

Rank 4
  • The company does not provide specific futuristic sales, revenue, or volume projections, maintaining a conservative approach to forward guidance.
  • Specialty chemicals are expected to grow, with commercialization underway for new products (e.g., polymer used in enhanced oil recovery), but exact sales or margin projections are not provided.
  • FY27 specialty chemical capacity utilization is expected to be better than FY25-26, though market conditions remain volatile.
  • Growth in specialty chemicals aims to increase the portfolio to at least 50% of business to be considered a true specialty chemical company.
  • Expansion efforts continue in Latin America, Japan, Korea, and China to replace lost European markets.
  • The company remains cautious due to volatile raw material prices (notably sulfur) and supply chain dynamics which influence production and sales volumes.

📈 Profitability & Margins

Rank 3
  • The management, represented by Bimal Goculdas, refrains from giving futuristic projections, maintaining focus on past and present performance.
  • Specialty chemical business capacity utilization is expected to be better in FY27 compared to FY25-26 but no specific growth figures provided.
  • Commercial sales have begun in specialty boron products (e.g., used in polymers for enhanced oil recovery), but projections on volume and margin are not available.
  • The company aims to increase the specialty chemical portfolio to at least 50% of revenues for a true specialty chemicals identity, which should enhance margins and earnings quality over time.
  • R&D spending is planned to increase, potentially driving future growth through process improvements and new product development.
  • Working capital and interest costs have risen due to higher raw material prices and inventory, but these are considered temporary factors linked to volatile market conditions.
  • Monetization of land assets could be used for CAPEX or debt reduction but timelines are uncertain.

🏗️ Capital Expenditure Plans

No information
  • The company received land near Ambernath (Nalimbi), currently under government custody due to pending registry; monetization plans are under consideration.
  • Proceeds from monetizing this land, once realized, could be used for CAPEX or debt reduction.
  • No specific timeline given for land registry transfer or monetization.
  • No definitive projections or details about upcoming capital expenditure on new plants or expansions were shared.
  • Focus remains on R&D with plans to increase intensity, supporting specialty chemical development.
  • Specialty chemical products under development are moving toward commercialization, but timelines and investment specifics for FY27/FY28 remain uncertain.
  • Overall, capital investments seem contingent on asset monetization and market dynamics rather than fixed scheduled projects.

💰 Fundraising & Capital Structure

No information
  • There is no explicit mention of any current or planned new fundraising through debt or equity in the transcript.
  • The company discussed using potential proceeds from land monetization for CAPEX or debt reduction but did not specify raising new funds.
  • Working capital borrowings have increased due to higher inventories and receivables, with interest rates around 8.75% to 9%, but this is not described as new fundraising.
  • Management emphasized operating within current resources and did not provide projections or plans for fresh equity or debt issuance.
  • Overall, no clear plans for fresh fundraising via debt or equity were disclosed.

📋 Order Book & Pipeline

No information
  • No specific details on current or expected order book or pending orders were provided during the conference call.
  • Bimal Goculdas mentioned ongoing commercial sales in specialty boron products but did not give projections on volumes or margins.
  • Discussions on specialty chemicals indicate progress towards commercial stages, but exact order quantities remain uncertain.
  • The supply situation for sulfur and related chemicals is dynamic, affecting production but no direct information on order backlog.
  • The company is exploring markets in Latin America, Japan, Korea, and China, with some new commercial traction, but no firm orders disclosed.
  • Overall, due to volatility in raw material supply and prices, management refrains from giving forward-looking projections on order books.

Key Metrics

Revenue

Rank 4

Margin

Rank 3

Capex

No information

Fundraise

No information

Order Book

No information

Frequently Asked Questions

What were DMCC Speciality Chemicals Ltd Q4 FY26 results?

The company does not provide specific futuristic sales, revenue, or volume projections, maintaining a conservative approach to forward guidance. The management, represented by Bimal Goculdas, refrains from giving futuristic projections, maintaining focus on past and present performance.

What is DMCC Speciality Chemicals Ltd share price analysis?

DMCC Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 26.0 with a market cap of ₹710 Cr. Investors should review the full earnings analysis for detailed insights.

Is DMCC Speciality Chemicals Ltd planning capital expenditure?

The company received land near Ambernath (Nalimbi), currently under government custody due to pending registry; monetization plans are under consideration.

Keep DMCC Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What DMCC Speciality Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Rossari Biotech (Q4 FY26)

    50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…

  • Pidilite Inds. (Q4 FY26)

    Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…

  • PCBL Chemical (Q4 FY26)

    The company has reduced overall borrowings by approximately INR 450 crores in the current year. Key concall takeaways from PCBL Chemical's Q4 FY26 earnings…

  • Aarti Industries (Q4 FY26)

    Capex planned around INR750-800 crore in FY27, mainly for Zone IV completion and new long-term contracts, supporting medium-term growth. Key concall takeaways…